Detalhe da pesquisa
1.
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.
Cell
; 176(4): 775-789.e18, 2019 02 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30595452
2.
Converting Cold into Hot Tumors by Combining Immunotherapies.
Cell
; 170(6): 1055-1056, 2017 09 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28886376
3.
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.
Cell
; 181(3): 747, 2020 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-32359441
4.
Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab.
N Engl J Med
; 389(19): 1790-1796, 2023 Nov 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37937778
5.
A prediction model for response to immune checkpoint inhibition in advanced melanoma.
Int J Cancer
; 154(10): 1760-1771, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38296842
6.
Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.
Proc Natl Acad Sci U S A
; 118(43)2021 10 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34670835
7.
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.
Int J Cancer
; 152(12): 2493-2502, 2023 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36843274
8.
Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers.
Curr Opin Oncol
; 35(2): 107-113, 2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36607824
9.
Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma.
Ann Surg Oncol
; 30(8): 5017-5026, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36991168
10.
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 573-586, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36203067
11.
Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice.
Int J Cancer
; 150(2): 317-326, 2022 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34520567
12.
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
N Engl J Med
; 381(7): 626-636, 2019 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31166680
13.
[18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma.
Eur J Nucl Med Mol Imaging
; 49(6): 2010-2022, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34957526
14.
Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial.
BMC Cancer
; 22(1): 851, 2022 Aug 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35927710
15.
Neoantigen landscape dynamics during human melanoma-T cell interactions.
Nature
; 536(7614): 91-5, 2016 08 04.
Artigo
Inglês
| MEDLINE | ID: mdl-27350335
16.
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.
Ann Intern Med
; 174(5): 641-648, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33587686
17.
Immunotherapy for cancer treatment during pregnancy.
Lancet Oncol
; 22(12): e550-e561, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34856152
18.
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial.
Lancet Oncol
; 22(12): 1681-1691, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34767759
19.
Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial.
Ann Surg
; 274(2): 383-389, 2021 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33843797
20.
Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. Reply.
N Engl J Med
; 388(9): 859-860, 2023 Mar 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36856631